Cspc Innovation Pharmaceutical Co.,Ltd.’s Net Profit Rose 12.7% in First Three Quarters of 2023

Cspc Innovation Pharmaceutical Co.,Ltd. (石药集团新诺威制药股份有限公司) (300765.SZ) reported a net profit of 583.5 million yuan in the first three quarters of 2023, up 12.7% year-on-year.

Meanwhile, the company posted 1.9 billion yuan in revenue, up 0.5% year-on-year.

At the end of the reporting period, it had 5.4 billion yuan in total assets and 464.4 million yuan in total liabilities, with a liability-to-asset ratio of 8.6%.